This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Acadia (ACHC) Buys CenterPointe Assets, Boosts Missouri Footprint
by Zacks Equity Research
Acadia Healthcare (ACHC) acquires the assets of Missouri-based CenterPointe Behavioral Health System in order to offer high-quality behavioral healthcare services across the state.
Select Medical's (SEM) Rising Stake in Concentra to Aid
by Zacks Equity Research
Select Medical Holdings (SEM) acquires the remaining Concentra stake from equity holders for $625.6 million.
Why Buying Molina Healthcare (MOH) is a Prudent Move Now?
by Zacks Equity Research
Molina Healthcare's (MOH) total revenues for 2021 are anticipated to be no less than $27.5 billion.
Cigna (CI), SRHS Tie Up to Offer Enhanced Care in Upstate SC
by Zacks Equity Research
Cigna (CI) inks a deal to expand ties with SRHS. The move equips both healthcare providers to jointly offer enhanced healthcare services across the Upstate community.
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network (Revised)
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
Humana (HUM) Down 7.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth (UNH) Unit Launches Plan, Boosts Arizona Presence
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary UnitedHealthcare unveils The Doctors Plan of Arizona that will offer high-quality and affordable care for two counties in Arizona.
Humana (HUM) Ties Up to Enhance Medicare Advantage Business
by Zacks Equity Research
Humana (HUM) forges an alliance with the Loudoun Medical Group to boost its Medicare Advantage portfolio.
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
UnitedHealth (UNH) Extends Plan Coverage in Massachusetts
by Zacks Equity Research
UnitedHealth Group's unit (UNH) provides an integrated health benefit plan in a bid to offer better health outcomes for eligible members in Massachusetts, who qualify for both Medicare and MassHealth.
Humana (HUM) to Provide Value-Based Care in Central Kansas
by Zacks Equity Research
Humana (HUM) expands the value-based agreement with Hutchinson Clinic in a bid to provide enhanced healthcare services to its MA members in central Kansas.
Humana (HUM) Ties Up With Allina Health to Boost Value-Based Care
by Zacks Equity Research
Humana (HUM) expands value-based agreement with Allina Health, which is aimed at offering enhanced outcomes for HUM's MA members in Minnesota.
Anthem (ANTM) to Acquire Integra to Enhance Medicaid Business
by Zacks Equity Research
Anthem (ANTM) to buy Integra Managed Care from a wholly-owned indirect unit of Personal Touch Holding Corporation to bolster its Medicaid Business profile.
Select Medical (SEM) Q3 Earnings Beat, Hikes '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) third-quarter results reflect solid revenues driven by strong segmental contributions, and an uptick in admissions and patient visits, partly offset by elevated costs.
Cigna (CI) Q3 Earnings Beat Estimates, Ups '21 EPS View
by Zacks Equity Research
Cigna's (CI) third-quarter results reflect solid segmental performances, consistent expense efficiency and continued medical membership growth.
Humana's (HUM) Earnings Beat Estimates in Q3, Surge Y/Y
by Zacks Equity Research
Humana's (HUM) Q3 results reflect a better revenue stream and strength in its Retail and Healthcare Services segments.
Humana (HUM) Q3 Earnings Top Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 4.77% and -0.88%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) to Post Earnings in Q3: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) Q3 results are likely to reflect growth in earnings and revenues.
Humana (HUM) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Humana's (HUM) third-quarter earnings are expected to have gained from higher revenues and a solid contribution from its Retail and Healthcare Services segments.
Humana (HUM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health (EHC) Rides on Solid Revenues, Expansion Plans
by Zacks Equity Research
Encompass Health (EHC) continues to gain, courtesy of sustained growth in revenues, sound expansion endeavors across the United States and a robust 2021 business outlook.
Anthem's (ANTM) MA Members to be Covered Under Highly Rated Plans
by Zacks Equity Research
Anthem's (ANTM) 72% Medicare Advantage members to be covered under highly rated plans starting 2022. The ratings reflect the company's commitment to provide better healthcare.
Molina (MOH) to Buy AgeWell's Medicaid Long Term Care Business
by Zacks Equity Research
Molina (MOH) inks a deal to acquire certain assets of AgeWell New York's Medicaid Managed Care Business for a value of $110M.
Humana's (HUM) 2022 Expansion Plan to Boost MA Customer Base
by Zacks Equity Research
Humana (HUM) declares enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties to offer improved health outcomes.
Humana (HUM), Kelsey-Seybold Clinic Tie Up for Better Healthcare
by Zacks Equity Research
Humana (HUM) inks a deal with Kelsey-Seybold Clinic in Houston to offer its Humana Medicare Advantage HMO members enriched healthcare facilities.